Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales.

Exact Sciences released data from a study of its blood-based colorectal cancer screening test that showed sensitivities of 88.3% for colorectal cancer and 31.2% for advanced precancerous lesions.

The patient can use his implant to turn on lights, make video calls, play music and shows, read books and buy products online without using his hands or voice.

Senseonics and commercial partner Ascensia Diabetes Care received clearance from the Food and Drug Administration for the first implantable glucose sensor that can be worn for one year, doubling the ...

Join us as we highlight the most impactful trends in the medical device industry and how the digital thread can help companies embrace these trends to improve business outcomes. With the rise of ...

The FDA posted a second Smiths recall on Wednesday related to a problem with certain ParaPac ventilator kits. A knob that sets the tidal volume, or the amount of air delivered with each breath, can ...

Laval, Canada-based Bausch Health announced plans in 2020 to separate Bausch + Lomb into an independent, publicly traded company. The intent was to separate the eye care business, which includes ...

ICU Medical paid $2.35 billion to buy Smiths Medical from London-based industrial conglomerate Smiths Group, adding syringe and ambulatory infusion pumps and vascular access and vital care devices to ...

Boston Scientific and Silk Road announced the merger in June. The deal valued Silk Road at $27.50 per share. Silk Road manufacturers devices used in a minimally invasive procedure called transcarotid ...